1. Home
  2. EXEL vs BROS Comparison

EXEL vs BROS Comparison

Compare EXEL & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • BROS
  • Stock Information
  • Founded
  • EXEL 1994
  • BROS 1992
  • Country
  • EXEL United States
  • BROS United States
  • Employees
  • EXEL N/A
  • BROS N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • BROS Restaurants
  • Sector
  • EXEL Health Care
  • BROS Consumer Discretionary
  • Exchange
  • EXEL Nasdaq
  • BROS Nasdaq
  • Market Cap
  • EXEL 9.4B
  • BROS 9.5B
  • IPO Year
  • EXEL 2000
  • BROS 2021
  • Fundamental
  • Price
  • EXEL $37.42
  • BROS $69.75
  • Analyst Decision
  • EXEL Buy
  • BROS Strong Buy
  • Analyst Count
  • EXEL 18
  • BROS 12
  • Target Price
  • EXEL $37.59
  • BROS $78.17
  • AVG Volume (30 Days)
  • EXEL 2.8M
  • BROS 3.4M
  • Earning Date
  • EXEL 04-29-2025
  • BROS 05-06-2025
  • Dividend Yield
  • EXEL N/A
  • BROS N/A
  • EPS Growth
  • EXEL 170.77
  • BROS 1127.26
  • EPS
  • EXEL 1.76
  • BROS 0.34
  • Revenue
  • EXEL $2,168,701,000.00
  • BROS $1,281,015,000.00
  • Revenue This Year
  • EXEL $5.45
  • BROS $25.68
  • Revenue Next Year
  • EXEL $10.32
  • BROS $22.48
  • P/E Ratio
  • EXEL $21.43
  • BROS $205.86
  • Revenue Growth
  • EXEL 18.50
  • BROS 32.64
  • 52 Week Low
  • EXEL $20.14
  • BROS $26.85
  • 52 Week High
  • EXEL $40.02
  • BROS $86.88
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 58.85
  • BROS 53.97
  • Support Level
  • EXEL $36.68
  • BROS $62.01
  • Resistance Level
  • EXEL $37.99
  • BROS $71.25
  • Average True Range (ATR)
  • EXEL 1.09
  • BROS 3.51
  • MACD
  • EXEL -0.11
  • BROS 0.40
  • Stochastic Oscillator
  • EXEL 49.87
  • BROS 86.57

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About BROS Dutch Bros Inc.

Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments company-operated shops and franchising and other.

Share on Social Networks: